Covid-19: What you need to know today

Vaccine development has traditionally been a risky business – not just because of the success rate, but also because the timelines involved (8-10 years) meant that developers were taking a big chance that the disease targeted by the vaccine would still be relevant (and a problem) a decade into the future.

from Hindustan Times - india https://ift.tt/39hPu0a